Helen Keller International
Dakar, Senegal
NCT Number: NCT00944398
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of targeted zinc fortification programs.
Looking for future studies?
Notify Me12 month–17 month
All sexes
Interventional
Phase 4
Dakar, Senegal
The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to young children. The following specific steps will be completed:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily consumption
Other names: Provital, CoAID
Liquid supplement containing zinc sulfate
Other names: Zinc sulfate and B vitamins, DSM
Liquid placebo supplement
Other names: B vitamins, DSM
Non-fortified complementary food.
Other names: Provital, CoAID
Time frame: 3 weeks
University of California, Davis
Other
Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585318
Child Nutrition Disorders, Iron Deficiencies
Guatemala City, Departamento de Guatemala, Guatemala
View Trial DetailsNCT02233764
Iron Deficiencies, Iron Deficiency
Bengaluru, Karnataka, India
View Trial DetailsNCT05085834
Cardiovascular Diseases, Inflammation
Cleveland, Ohio, United States
View Trial DetailsNCT03283813
Body Weight, Glucose Metabolism Disorders
Novara, Italy
View Trial Details